The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Hebrew University researcher develops compounds to control bacteria

A method for controlling bacterial activity without antibiotics by interfering with their communication process has been developed by a young Hebrew University of Jerusalem researcher.

For his work, Adel Jabbour will be presented with a Kaye Innovation Award on June 6 during the 68th meeting of the Hebrew University Board of Governors. Jabbour, a Ph.D. student, conducted his work under the supervision of Prof. Morris Srebnik of the School of Pharmacy and Prof. Doron Steinberg of the Faculty of Dental Medicine. Also working on the project is graduate student Moshe Bronstein

Most human and animal diseases are associated with bacteria that are assembled in "communities," called biofilms, that attach themselves to many surfaces, such as live tissues, implants and teeth. Biofilm can also be found on artificial surfaces such as water pipes or air-conditioning ducts.

Only recently has it been discovered that the bacteria assembled in biofilms have a network of communication between them called "quorum sensing," which controls their collective activity (or lack thereof). These sensing signals control the physiology and pathogenicity of the bacteria in the biofilms. A boron-based molecule that is produced by these bacteria, called auto inducer-2, controls the signals in this quorum sensing process.

Jabbour has succeeded in synthesizing modified chemical compounds, resembling the structure of the natural auto inducer-2, that can disrupt the signaling. By altering the molecular structure in these compounds, Jabbour was able to show that it is possible to control the quorum sensing responses in order to "deceive" the bacteria. The modified compounds distort the signaling that sets off the bacterial changes, making it possible to seriously hamper the bacterial action, or, if so desired, even enhance it (in those cases where the bacteria are beneficial).

Control over quorum sensing provides a promising avenue for future treatment of bact
'"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-2-588-2904
The Hebrew University of Jerusalem
2-Jun-2005


Page: 1 2

Related medicine news :

1. Hebrew University research shows developmental problems for siblings of autistic children
2. Hebrew University scientists develop potential new epilepsy drug
3. Hebrew University researchers succeed in observing for 1st time how DNA damage is identified
4. Hebrew University scientists develop prototype drug to prevent osteoporosis
5. Hebrew University receives its largest NIH research grant ever -- $5.6 million biodefense award
6. Novel approach for eradicating prostate cancer wins award for young Hebrew University researcher
7. New eye treatment technology wins Kaye Award for Hebrew University researcher
8. Derivatives of cannabis for anti-cancer treatment win Kaye Award for Hebrew University student
9. Indiana University Imaging Center receives $6M grant for kidney research
10. University hospitals wins multiple national IT awards for electronic patient data bank
11. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University

Post Your Comments:
(Date:11/25/2009)...,Nov.25/PRNewswire-USNewswire/--TheBlackAIDSInstit...executiveleadershipfor2010. ,, ThenewBoardMembe...publicpolicy,law,finance,governmenthealthprograms,...comesfromawiderangeofpersonalbackgroundsincludingb...thHIVthemselves,andrepresentingmultipleagegroups. ...
(Date:11/25/2009)... found evidence of a statistically significant sur...ts whose estrogen receptor (ER)-positive tumors ha...erine-118 (ER-alpha S118-P), according to a brief ... Journal of the National Cancer Institute . , Ap... to tamoxifen. Preclinical studies have shown that...
(Date:11/25/2009)... used to fight rheumatoid arthritis, could help ne... WEDNESDAY, Nov. 25 (HealthDay News) -- A drug com...umatoid arthritis now also shows some promise in h...es. , The drug, rituximab (Rituxan), helped pat...en though the disease had destroyed some of their ...
(Date:11/25/2009)...ote, CDC sees few signs of trouble with the H1N1 v...ay News) -- The ongoing H1N1 swine flu pandemic ma...s among younger patients, a U.S. health official s...serious pneumococcal infections around the country...ter for Immunization and Respiratory Diseases at t...
(Date:11/25/2009)... -- A cancer vaccine carried into the body on a ca...e first to successfully eliminate tumors in mammal...ence Translational Medicine . , The new approach...arvard University, uses plastic disks impregnated ...he skin to reprogram the mammalian immune system t...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
(Date:11/25/2009)...v.25/PRNewswire-FirstCall/--Abaxis,Inc.(Nasdaq: AB...carebloodanalysissystems,announcedtodaythatClintSe...tatthe21stAnnualPiperJaffrayHealthCareConferenceon...willbeheldattheNewYorkPalaceHotelinNewYorkCity. ,...sandmarketsportablebloodanalysissystemsforuseinany...
(Date:11/25/2009)....25/PRNewswire/--CempraPharmaceuticalsInc.todayann...ecutiveofficer,willpresentatthePiperJaffray21stAnn...9,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Fernande...bioticclinicalprogramsforthetreatmentofdrug-resist...aceuticals ,, Foundedin2006,CempraPharmaceutic...
(Date:11/25/2009)...SYDNEY,Nov.25/PRNewswire-FirstCall/--HeartWareInte...vatorandprovideroflessinvasive,miniaturizedcircula...ofadvancedheartfailure,todayannouncedthatitissched...erJaffrayHealthCareConferenceat8:00amESTonWednesda...orkPalaceHotel,December1-2. ,, Alivewebcastofth...
Breaking Medicine Technology:Pre clinical Data Show OrbusNeichs Combo Bio engineered Sirolimus Eluting Stent May Offer Advantages to Current Drug Eluting Stent Technologies 5039 1Pre clinical Data Show OrbusNeichs Combo Bio engineered Sirolimus Eluting Stent May Offer Advantages to Current Drug Eluting Stent Technologies 5039 2Pre clinical Data Show OrbusNeichs Combo Bio engineered Sirolimus Eluting Stent May Offer Advantages to Current Drug Eluting Stent Technologies 5039 3SPIRIT IV trial shows everolimus stent sets new standard for event free survival 58174 1SPIRIT IV trial shows everolimus stent sets new standard for event free survival 58174 2Depression and anxiety disorders of adolescents are not the same thing 10069 1
Other News:
...(LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced toda...olar Disorder (BPD), or an anxiety disorder may al...y Disorder (ADHD), according to a longitudinal ret... at a major medical meeting of child and adolescen...
...he U.S. economy. The combination of systems analys...he implementation of ideas that produce continuous...ntributing factor. ...At the same time, important ...imary and secondary education have been left behin...
...east cancer, it may not matter whether they receiv...adiation therapy, according to a new review of stu...he cancer return are similar in all three cases, i...seven months after surgery, the review concludes.....
...e examining a way of using bacteria to manufacture...re difficult to create synthetically on a lab benc...lly produce antibiotics called prodiginines.... Th... interest as they can be used to target and kill c...
health news:Many adults with psychiatric disorders may also have undiagnosed ADHD 2health news:Former Treasury Secretery O'Neill will urge scientists in Pittsburgh to speed social change 2health news:Order of chemotherapy, radiation has no effect on breast cancer survival 2
...o punish doctors who make mistakes is questionable.....Citing the case of Feda Mulhem, who was sentence...mistaken injection of a drug into the spine of a t...as not seeking to harm his patient. In fact he was...
... prepare women for operative deliveries (caesarean...to study in this week's BMJ.......Researchers inte...ery in the second stage of labour at two UK hospit...prepared for operative delivery and thought that t...
... and developments in anaesthesia is launched in th...eviews patients' concerns about anaesthesia..........ospital, Middlesex, UK, outline how patients sched...oncerns about their safety, outcome, and comfort. ...
...s week's issue of THE LANCET highlight how assessm...ncentrations could have potential as low-cost alte...infected children in less-developed countries. ......te count and viral-load assessment (conventional p...
health news:Potential low-cost options for monitoring HIV-1-infected children in less-developed countries 2